| pubmed-article:20933321 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20933321 | lifeskim:mentions | umls-concept:C0025266 | lld:lifeskim |
| pubmed-article:20933321 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:20933321 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:20933321 | lifeskim:mentions | umls-concept:C0138741 | lld:lifeskim |
| pubmed-article:20933321 | lifeskim:mentions | umls-concept:C1521970 | lld:lifeskim |
| pubmed-article:20933321 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
| pubmed-article:20933321 | lifeskim:mentions | umls-concept:C0597198 | lld:lifeskim |
| pubmed-article:20933321 | lifeskim:mentions | umls-concept:C1418289 | lld:lifeskim |
| pubmed-article:20933321 | lifeskim:mentions | umls-concept:C0449820 | lld:lifeskim |
| pubmed-article:20933321 | lifeskim:mentions | umls-concept:C1514863 | lld:lifeskim |
| pubmed-article:20933321 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:20933321 | pubmed:dateCreated | 2011-3-18 | lld:pubmed |
| pubmed-article:20933321 | pubmed:abstractText | Prostate cancer antigen 3 (PCA3) is considered to be prostate cancer (PCa) specific and highly overexpressed in cancer. Therefore a high PCA3 score should result in a high positive predictive value (PPV) and specificity for a positive biopsy. | lld:pubmed |
| pubmed-article:20933321 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20933321 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20933321 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20933321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20933321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20933321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20933321 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20933321 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:20933321 | pubmed:issn | 1873-7560 | lld:pubmed |
| pubmed-article:20933321 | pubmed:author | pubmed-author:SchröderFritz... | lld:pubmed |
| pubmed-article:20933321 | pubmed:author | pubmed-author:RoobolMonique... | lld:pubmed |
| pubmed-article:20933321 | pubmed:author | pubmed-author:HesselsDaphne... | lld:pubmed |
| pubmed-article:20933321 | pubmed:author | pubmed-author:WoltersTineke... | lld:pubmed |
| pubmed-article:20933321 | pubmed:author | pubmed-author:van den... | lld:pubmed |
| pubmed-article:20933321 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:20933321 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:20933321 | pubmed:copyrightInfo | Copyright © 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved. | lld:pubmed |
| pubmed-article:20933321 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20933321 | pubmed:volume | 58 | lld:pubmed |
| pubmed-article:20933321 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20933321 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20933321 | pubmed:pagination | 893-9 | lld:pubmed |
| pubmed-article:20933321 | pubmed:meshHeading | pubmed-meshheading:20933321... | lld:pubmed |
| pubmed-article:20933321 | pubmed:meshHeading | pubmed-meshheading:20933321... | lld:pubmed |
| pubmed-article:20933321 | pubmed:meshHeading | pubmed-meshheading:20933321... | lld:pubmed |
| pubmed-article:20933321 | pubmed:meshHeading | pubmed-meshheading:20933321... | lld:pubmed |
| pubmed-article:20933321 | pubmed:meshHeading | pubmed-meshheading:20933321... | lld:pubmed |
| pubmed-article:20933321 | pubmed:meshHeading | pubmed-meshheading:20933321... | lld:pubmed |
| pubmed-article:20933321 | pubmed:meshHeading | pubmed-meshheading:20933321... | lld:pubmed |
| pubmed-article:20933321 | pubmed:meshHeading | pubmed-meshheading:20933321... | lld:pubmed |
| pubmed-article:20933321 | pubmed:meshHeading | pubmed-meshheading:20933321... | lld:pubmed |
| pubmed-article:20933321 | pubmed:meshHeading | pubmed-meshheading:20933321... | lld:pubmed |
| pubmed-article:20933321 | pubmed:meshHeading | pubmed-meshheading:20933321... | lld:pubmed |
| pubmed-article:20933321 | pubmed:meshHeading | pubmed-meshheading:20933321... | lld:pubmed |
| pubmed-article:20933321 | pubmed:meshHeading | pubmed-meshheading:20933321... | lld:pubmed |
| pubmed-article:20933321 | pubmed:meshHeading | pubmed-meshheading:20933321... | lld:pubmed |
| pubmed-article:20933321 | pubmed:meshHeading | pubmed-meshheading:20933321... | lld:pubmed |
| pubmed-article:20933321 | pubmed:meshHeading | pubmed-meshheading:20933321... | lld:pubmed |
| pubmed-article:20933321 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20933321 | pubmed:articleTitle | Performance of prostate cancer antigen 3 (PCA3) and prostate-specific antigen in Prescreened men: reproducibility and detection characteristics for prostate cancer patients with high PCA3 scores (? 100). | lld:pubmed |
| pubmed-article:20933321 | pubmed:affiliation | Erasmus Medical Center, University Medical Center, Rotterdam, The Netherlands. m.roobol@erasmusmc.nl | lld:pubmed |
| pubmed-article:20933321 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20933321 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| entrez-gene:354 | entrezgene:pubmed | pubmed-article:20933321 | lld:entrezgene |
| entrez-gene:50652 | entrezgene:pubmed | pubmed-article:20933321 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:20933321 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:20933321 | lld:entrezgene |
